National Community Pharmacists Association
PGY2 Pediatric Pharmacy Residency
National Community Pharmacists Association, Washington, District of Columbia, us, 20022
The Children's National Postgraduate Year Two (PGY2) Pediatric Pharmacy Residency Program provides learning experiences centered on patient care and practice management that will enable residency graduates to pursue advanced clinical pharmacist and clinical specialist positions in pediatrics after completion of the program. The residency program will also provide teaching opportunities that will develop pedagogical skills in the context of adjunct faculty appointment with affiliated pharmacy schools. An optional teaching certificate program will be available through ASHP or University of Maryland School of Pharmacy (this will be required for residents who have not previously completed one). The Division of Pharmacy is affiliated with Howard University School of Pharmacy, University of Maryland School of Pharmacy, Virginia Commonwealth University and Shenandoah University as well as other pharmacy schools around the country.
More than 100 pharmacists have completed a residency at Children’s National since the start of the program in 1980. Children’s National is a participating member of the ASHP Residency Matching Program. The PGY2 Pediatric Pharmacy Residency (traditional) has been accredited since 2012 with two positions available. The PGY2 Pediatric Pharmacy Residency with Pediatric Specialist Pathway in Critical Care has been accredited since 2023 and has one position available.
Potential candidates for the Children's National Hospital Pharmacy Postgraduate Year Two (PGY2) Residency Programs should submit a formal application no later than
January 2, 2025
to be considered for the incoming class to begin July 1, 2025. The following should be included with the formal application submission in PHORCAS: Curriculum Vitae - should include (but not be limited to) schools or universities attended with dates of enrollment; degrees conferred or expected; honors and awards; extracurricular activities; work experience; completed and anticipated clinical rotation experiences. Three letters of recommendation:
Two from clinical or academic faculty; one from the applicant’s most recent employer. Each letter of recommendation should provide comments in at least three fields, preferably the fields of:
Independence and resourcefulness. Ability to work with peers and communicate effectively. Emotional stability and maturity.
Letters of recommendation should be directly submitted by the author to PhORCAS.
An on-site or virtual interview at Children’s National Hospital is required. Applicants will be invited to interview based on review of their formal application, personal statement, and letters of recommendation. On-site and virtual interviews will be scheduled for a mutually available date between late January and early March 2025.
#J-18808-Ljbffr
January 2, 2025
to be considered for the incoming class to begin July 1, 2025. The following should be included with the formal application submission in PHORCAS: Curriculum Vitae - should include (but not be limited to) schools or universities attended with dates of enrollment; degrees conferred or expected; honors and awards; extracurricular activities; work experience; completed and anticipated clinical rotation experiences. Three letters of recommendation:
Two from clinical or academic faculty; one from the applicant’s most recent employer. Each letter of recommendation should provide comments in at least three fields, preferably the fields of:
Independence and resourcefulness. Ability to work with peers and communicate effectively. Emotional stability and maturity.
Letters of recommendation should be directly submitted by the author to PhORCAS.
An on-site or virtual interview at Children’s National Hospital is required. Applicants will be invited to interview based on review of their formal application, personal statement, and letters of recommendation. On-site and virtual interviews will be scheduled for a mutually available date between late January and early March 2025.
#J-18808-Ljbffr